Evidence map›Paper›PMID 32190709›Full record

ArticleOpen forum infectious diseases2020

High Burden of

Catherine G Sutcliffe, Lindsay R Grant, Angelina Reid, Grace Douglass, Laura B Brown, Kamellia Kellywood, Robert C Weatherholtz, Robin Hubler, Alvaro Quintana, Ryan Close and 4 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Understanding Community Perspectives onInternational journal of environmental research and public health · 2026
    Article
  2. Population genomic variation inMicrobial genomics · 2026
    Article
  3. Article
  4. Review
  5. Antibiotics (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Catherine G SutcliffeCenter for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID 0000-0001-8512-8326
Lindsay R GrantCenter for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Angelina ReidCenter for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Grace DouglassCenter for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Laura B BrownCenter for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Kamellia KellywoodCenter for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Robert C WeatherholtzCenter for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Robin HublerPfizer Vaccine Medical Development, Scientific and Clinical Affairs, Collegeville, Pennsylvania, USA.
Alvaro QuintanaPfizer Vaccine Medical Development, Scientific and Clinical Affairs, Collegeville, Pennsylvania, USA.
Ryan CloseWhiteriver Service Unit, Indian Health Service, Whiteriver, Arizona, USA.
James B McAuleyWhiteriver Service Unit, Indian Health Service, Whiteriver, Arizona, USA.
Mathuram SantoshamCenter for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Katherine L O'BrienCenter for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Laura L HammittCenter for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Johns Hopkins University · USPfizer (United States) · USIndian Health Service · USRush University Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study was done to determine the burden of invasive

methodsActive population and laboratory-based surveillance for invasive

resultsFifty-three cases were identified. Most cases were adults (90.6%) and had ≥1 underlying medical condition (86.8%), the most common of which were diabetes (49.1%) and obesity (41.5%). A total of 26.4% cases were categorized as community acquired. Most infections were methicillin-resistant (75.5%). A total of 7.5% of cases required amputation, and 7.7% of cases died within 30 days of initial culture. The incidence of invasive

conclusionsThis community has a disproportionately high burden of invasive methicillin-resistant

Indexed as

invasive bacterial infectionsMRSANative Americanssurveillance

Identifiers

PMID32190709
PMCPMC7066796
OpenAlexW3008467708

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.